IG for MIS-C: Lessons Learned

By Bruce Buckley
LAS VEGAS—In the spring of 2020, Children’s Hospital New Orleans began using high-dose immunoglobulin (IG) therapy along with other immunomodulatory drugs to treat pediatric patients presenting with severe systemic inflammation similar to that of Kawasaki disease, according to Ken Paris, MD, MPH, an associate professor of pediatrics at LSU Health Sciences Center New Orleans and the hospital’s clinical service line chief for allergy and immunology.